• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia

tetano

Editor, Senior Moderator
Nat Commun


. 2024 May 7;15(1):3814.
doi: 10.1038/s41467-024-48098-3. High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia

Sheikh Jarju[SUP] #[/SUP][SUP] 1 [/SUP], Rhys D Wenlock[SUP] #[/SUP][SUP] 1 [/SUP], Madikoi Danso[SUP] 1 [/SUP], Dawda Jobe[SUP] 1 [/SUP], Ya Jankey Jagne[SUP] 1 [/SUP], Alansana Darboe[SUP] 1 [/SUP], Michelle Kumado[SUP] 1 [/SUP], Yusupha Jallow[SUP] 1 [/SUP], Mamlie Touray[SUP] 1 [/SUP], Ebrima A Ceesay[SUP] 1 [/SUP], Hoja Gaye[SUP] 1 [/SUP], Biran Gaye[SUP] 1 [/SUP], Abdoulie Tunkara[SUP] 1 [/SUP], Sheriff Kandeh[SUP] 1 [/SUP], Marie Gomes[SUP] 1 [/SUP], Ellen Lena Sylva[SUP] 1 [/SUP], Fatoumata Toure[SUP] 1 [/SUP], Hailey Hornsby[SUP] 2 3 [/SUP], Benjamin B Lindsey[SUP] 2 3 [/SUP], Martin J Nicklin[SUP] 2 3 [/SUP], Jon R Sayers[SUP] 2 3 [/SUP], Abdul K Sesay[SUP] 1 [/SUP], Adam Kucharski[SUP] 4 [/SUP], David Hodgson[SUP] 4 [/SUP], Beate Kampmann[SUP] 5 6 [/SUP], Thushan I de Silva[SUP] 7 8 9 [/SUP]



Affiliations
Abstract

Little is known about SARS-CoV-2 infection risk in African countries with high levels of infection-driven immunity and low vaccine coverage. We conducted a prospective cohort study of 349 participants from 52 households in The Gambia between March 2021 and June 2022, with routine weekly SARS-CoV-2 RT-PCR and 6-monthly SARS-CoV-2 serology. Attack rates of 45% and 57% were seen during Delta and Omicron BA.1 waves respectively. Eighty-four percent of RT-PCR-positive infections were asymptomatic. Children under 5-years had a lower incidence of infection than 18-49-year-olds. One prior SARS-CoV-2 infection reduced infection risk during the Delta wave only, with immunity from ≥2 prior infections required to reduce the risk of infection with early Omicron lineage viruses. In an African population with high levels of infection-driven immunity and low vaccine coverage, we find high attack rates during SARS-CoV-2 waves, with a high proportion of asymptomatic infections and young children remaining relatively protected from infection.


 
Back
Top Bottom